Bryan O’Donnell, Head of Quality at Gaelic Laboratories, explains how to navigate GMP challenges to ensure your company ...

This article is authored by Ranjit Barshikar, CEO, QbD International, CGMP Consulting, United Nations Adviser.

The US Food and Drug Administration (FDA) has issued several warning letters to pharmaceutical manufacturers in India and ...

This strategy enables Pfizer to maintain a strong foothold in the generic drug market while also protecting its revenue ...

India's pharmaceutical sector is witnessing remarkable growth, almost achieving its export target before FY25. Drug ...

At the 63rd Annual Day Celebrations of the Indian Drug Manufacturers Association (IDMA) in Mumbai recently, Dr Rajeev Raghuvanshi, Drugs Controller General of India (DCGI), delivered a compelling ...

Indian pharma strengthens deploying compressed air dryers in sync with revised Schedule M norms: Nandita Vijayasimha, Bengaluru Tuesday, February 4, 2025, 08:00 Hrs [IST] Indian p ...

Q1 2025 Earnings Call Transcript February 10, 2025 Arrowhead Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-1.39 EPS, expectations were $-0.42. Chris Anzalone: Thanks, Vince.